TMCI

#3097
Treace Medical Concepts, Inc. - Common Stock
3.4 6 USD
+12.34%
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
3.46
3.46
Range Annuel
1.17
7.78
Changement quotidien
+12.34%
Changement Mensuel
+95.48%
Evolution sur 6 mois
+18.49%
Changement Annuel
-40.45%
Clôture Précédente
3.0 8
Open
3.4 6
Low
3.4 6
High
3.4 6
Volume
60
Afficher le graphique complet Full chart

Financials

Aperçu Relevé Statistiques
Trimestriel Annuel
  • Market Capitalization 224.46 M
  • Employee 450
  • Founded 2014
  • CEO N/A
  • Website www.treace.com
  • Headquarter Florida, United States
  • FIGI BBG00GQKR6M4
  • Industry Dispositifs Médicaux
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-2.63
ratio cours/chiffre d'affaires
0.73

Treace Medical Concepts, Inc. - Common Stock

Treace Medical Concepts, Inc. is a medical device company, headquartered in Ponte Vedra Beach, Florida, specializing in the design, manufacture, and marketing of foot and ankle surgical devices and biologics. Lapiplasty, Treace’s novel primary surgical product, advanced the treatment of bunions, surgically correcting the metatarsal bone, for the first time, in all three dimensions. In March 2021, Treace announced its intent to launch an initial public offering. Trading on the Nasdaq under the ticker symbol “TMCI”, Treace opened its IPO in April 2021.

Nouvelles